Detailed description of a prepregnancy care program and its impact on maternal glucose control, weight gain, and dropouts

Diabetes Metab Res Rev. 2017 Feb;33(2). doi: 10.1002/dmrr.2838. Epub 2016 Aug 18.

Abstract

Background: The aim of this study was to analyze the clinical and metabolic changes observed during a prepregnancy care (PPC) program.

Methods: We performed a retrospective, observational, cohort study of 104 women with type 1 diabetes initiating a PPC program from 2011 to 2014. The outcomes measured were changes in HbA1c levels, weight and hypoglycemic events during PPC. Risk factors associated with severe hypoglycemia events, achieving the HbA1c target and dropouts were evaluated.

Results: HbA1c decreased from 7.2 ± 0.8% (55.3 ± 8.8 mmol/mol) to 6.7 ± 0.9% (49.8 ± 10.3 mmol/mol) (P < .001) within a median of 14.2 months (interquartile interval 5.4-23.2); 71.2% obtained HbA1c < 7% (53 mmol/mol). HbA1c at the end of PPC was associated with baseline HbA1c (β = .318, P = .001) and the number of previous pregnancies (β = .224, P = .038), PPC was accompanied by 1.4 ± 4.0 kg weight gain (P = .003) without changes in severe hypoglycemic events. The risk factors for severe hypoglycemia were severe hypoglycemic events during the 2 years before (odds ratio [OR] 11.99, confidence interval 95% 1.89-75.95) and PPC duration (OR 1.09, 1.03-1.16). A total of 33 patients (31.7%) dropped out from PPC during follow-up, with dropout being associated with age (OR 1.17, 1.04-1.36) and PPC duration (OR 1.06, 1.02-1.11).

Conclusions: Our PPC program was associated with an improvement in glycemic control without a significant increase in severe hypoglycemic events, although with some weight gain. A considerable number of patients dropped out during follow-up, this being related to older age and a longer duration of the program. This information could be of help to design new and more effective PPC approaches. Copyright © 2016 John Wiley & Sons, Ltd.

Keywords: hypoglycemia; prepregnancy care; type 1 diabetes mellitus; weight gain.

Publication types

  • Clinical Trial
  • Observational Study

MeSH terms

  • Adult
  • Blood Glucose / analysis
  • Body Weight
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / prevention & control*
  • Female
  • Follow-Up Studies
  • Glycated Hemoglobin / analysis
  • Humans
  • Hyperglycemia / etiology
  • Hyperglycemia / prevention & control*
  • Hypoglycemia / etiology
  • Hypoglycemia / prevention & control*
  • Hypoglycemic Agents / pharmacology*
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy in Diabetics / physiopathology*
  • Prenatal Care
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Weight Gain*

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • hemoglobin A1c protein, human